Targeting the Hepatocyte Growth Factor/c-Met Signaling Pathway in Renal Cell Carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference82 articles.
1. Cancer statistics, 2012.;Siegel;Cancer J Clin,2012
2. Hereditary and sporadic papillary renal carcinomas with c-Met mutations share a distinct morphological phenotype.;Lubensky;Am J Pathol,1999
3. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.;Schmidt;Nat Genet,1997
4. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.;Schmidt;Oncogene,1999
5. Identification of the hepatocyte growth factor receptor as the c-Met proto-oncogene product.;Bottaro;Science,1991
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The efficacy and safety of cabozantinib in patients with metastatic or advanced renal cell carcinoma: a systematic review and meta-analysis;Baylor University Medical Center Proceedings;2024-06-17
2. Association analysis of hepatocellular carcinoma‐related hub proteins and hub genes;PROTEOMICS – Clinical Applications;2023-06-14
3. c-Met and EPHA7 Receptor Tyrosine Kinases Are Related to Prognosis in Clear Cell Renal Cell Carcinoma: Focusing on the Association with Myoferlin Expression;Cancers;2022-02-21
4. Roles of MET in human cancer;Clinica Chimica Acta;2022-01
5. Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance);Clinical Cancer Research;2021-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3